{"cdcTestId":"2015-0016","testcaseName":"Zoster: Patient is overdue at 62 years of age for Zoster dose ","vaccineGroup":"ZOSTER","evaluationTestType":"No Doses Administered","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1960-10-03T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[]},"forecast":{"forecastNum":"1","earliestDate":"2010-10-03T00:00:00","recommendedDate":"2010-10-03T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[],"dateAdded":"2015-06-23T00:00:00","dateUpdated":"2018-04-19T07:31:54.666","generalDescription":"This test case describes when a patient is 62 years of age and has not been administered a Zoster vaccine, that dose 1 (Shingrix) of the 2 dose series should be forecasted.","changedInVersion":"3.4","reasonForChange":"V3.4: Test case updated to accommodate new ACIP Zoster recommendations.\nV2.0: New test case for version 2.0 which expanded scope into Adult recommendations"}